April 17, 2014 6:06 PM ET

Pharmaceuticals

Company Overview of MSD K.K.

Executive Profile

David Westbrook Anstice

Non-Executive Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 5 different industries.

See Board Relationships
65$234,198

Background

Mr. David Westbrook Anstice served as the President of MSD K.K. Mr. Anstice served as Executive Vice President of Strategy Initiatives at Merck & Co. Inc., from September 2006 to September 2008. He served as the President of Human Health of Merck & Co., Inc. from January 2003 to September 2006 and was responsible for its prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and its joint venture relationship with Schering-Plough. He spent ...

Corporate Headquarters

Kitanomaru Square
Tokyo, -- 102-8667

Japan

Phone: 81 3 6272 1000
Fax: 81 3 6238 9057

Board Members Memberships

Representative Director
Trustee
Director
2008-Present
Non-Executive Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee
2008-Present
Director
2011-Present
Independent Director and Member of Compensation Committee

Education

Bachelor's Degree 1970
University Of Sydney

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$234,198
Total Calculated Compensation$234,198
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Victor Grifols Roura Chairman, Chief Executive Officer, President, Managing Director and Member of Appointments & Remuneration Committee
Grifols, S.A.
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Kiran Mazumdar-Shaw B.Sc (Hons), PGD in Malting & BrewingFounder, Chairman, Managing Director, Member of Share Transfer Committee and Member of Investor Grievances Committee
Biocon Limited
$13.2M
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MSD K.K., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.